Ecmo Machine Market Size, Share, Industry Trends and Forecast to 2030

What is the Market Size & CAGR of ECMO Machine market in 2021?

The global ECMO machine market had a market size of USD 307.8 million in 2021 and is expected to grow at a CAGR of 4.6% from 2021 to 2028. The market is anticipated to reach USD 431.2 million by the end of 2028. The ECMO machine market is driven by factors such as the increasing prevalence of cardiac and respiratory diseases, advancements in technology, and the growing demand for intensive care units (ICUs) worldwide. Furthermore, the rising geriatric population and the impact of COVID-19 have also contributed to the growth of the ECMO machine market.

COVID-19 Impact on the ECMO Machine Market

The COVID-19 pandemic has had a significant impact on the ECMO machine market. With the sudden surge in cases of severe respiratory failure due to COVID-19, the demand for ECMO machines skyrocketed. Hospitals and healthcare facilities around the world faced challenges in meeting the increased need for ECMO machines, leading to supply shortages and delays in treatment for critically ill patients. The pandemic also highlighted the importance of ECMO machines in providing life-saving support to patients with severe respiratory conditions.

ECMO Machine Dynamics

The ECMO machine market is driven by several dynamics, including technological advancements, increasing prevalence of cardiac and respiratory diseases, growing demand for intensive care units, and rising geriatric population. Furthermore, factors such as the impact of COVID-19, advancements in healthcare infrastructure, and the growing focus on improving patient outcomes have also contributed to the growth of the ECMO machine market. However, challenges such as high cost of ECMO treatment, limited availability of trained healthcare professionals, and stringent regulatory requirements may hinder market growth.

Segments and Related Analysis

The ECMO machine market can be segmented based on modality, application, and region. By modality, the market is segmented into venoarterial (VA) ECMO and venovenous (VV) ECMO. The VA ECMO segment accounted for the largest market share in 2021, driven by its ability to provide circulatory support to patients with cardiac failure. By application, the market is segmented into cardiac support, respiratory support, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory support segment dominated the market in 2021, owing to the increasing number of patients with severe respiratory failure.

By Region Analysis

The ECMO machine market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the largest market share in 2021, driven by the presence of well-established healthcare infrastructure, high adoption of advanced medical technologies, and increasing prevalence of cardiac and respiratory diseases. Europe followed closely behind, with significant growth in the ECMO machine market attributed to the rising geriatric population and advancements in healthcare facilities. The Asia Pacific region is expected to witness the fastest growth due to the increasing focus on improving intensive care units and the rising demand for ECMO machines in countries like China and India.

Key Market Players and Competitive Landscape

Key players in the ECMO machine market include Getinge AB, LivaNova PLC, Medtronic plc, Terumo Corporation, and Siemens Healthineers AG. These companies are focusing on strategic partnerships, product launches, and acquisitions to strengthen their market position. For instance, in 2021, Getinge AB launched a next-generation ECMO machine with advanced features to enhance patient care. The competitive landscape of the ECMO machine market is characterized by intense competition, technological advancements, and increasing investments in research and development. Market players are constantly innovating their product offerings to cater to the evolving needs of healthcare providers and patients.

Recent Happenings in the ECMO Machine Market

In recent years, the ECMO machine market has witnessed several developments aimed at enhancing patient outcomes and improving treatment options. For example, in 2021, LivaNova PLC announced the launch of a portable ECMO machine designed for use in ambulances and transport vehicles. This innovation has facilitated the timely delivery of ECMO therapy to critically ill patients during transport. Additionally, Medtronic plc collaborated with leading research institutions to conduct clinical trials evaluating the efficacy of ECMO treatment in patients with severe respiratory failure. These developments underscore the growing significance of ECMO machines in the field of critical care medicine and highlight the continuous efforts of market players to expand their product offerings and improve patient care.